IL-1β associations with posttraumatic epilepsy development: A genetics and biomarker cohort study

Epilepsia

Volumn 55, Issue 7, 2014, Pages 1109-1119

  Diamond, Matthew L ^a   Ritter, Anne C ^a   Failla, Michelle D ^a,b   Boles, Jennifer A ^a   Conley, Yvette P ^b   Kochanek, Patrick M ^a,c   Wagner, Amy K ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Genetic variation; IL 1 ; Inflammation; Posttraumatic epilepsy; Traumatic brain injury

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CAUCASIAN; CEREBROSPINAL FLUID; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRONIC MEDICAL RECORD; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY;

GENETIC VARIATION; IL-1Β; INFLAMMATION; POSTTRAUMATIC EPILEPSY; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; EPILEPSY, POST-TRAUMATIC; FEMALE; GENETIC MARKERS; GENETIC VARIATION; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84904401051     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12628     Document Type: Article

References (55)

1. Englander J, Bushnik T, Duong TT, et al. Analyzing risk factors for late posttraumatic seizures: a prospective, multicenter investigation. Arch Phys Med Rehabil 2003; 84: 365-373.
2. Temkin NR,. Risk factors for posttraumatic seizures in adults. Epilepsia 2003; 44: 18-20.
3. Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998; 338: 20-24.
4. Englander J, Bushnik T, Wright JM, et al. Mortality in late post-traumatic seizures. J Neurotrauma 2009; 26: 1471-1477.
5. Kolakowsky-Hayner SA, Wright J, Englander J, et al. Impact of late post-traumatic seizures on physical health and functioning for individuals with brain injury within the community. Brain Inj 2013; 27: 578-586.
6. Formisano R, Barba C, Buzzi MG, et al. The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury. Brain Inj 2007; 21: 499-504.
7. Vezzani A, Ravizza T, Balosso S, et al. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008; 49 (Suppl. 2): 24-32.
8. Holtman L, van Vliet EA, Aronica E, et al. Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy. Epilepsia 2013; 54: 589-595.
9. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8: 752-758.
10. Ferrari D, Villalba M, Chiozzi P, et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 1996; 156: 1531-1539.
11. Lu KT, Wang YW, Yang JT, et al. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J Neurotrauma 2005; 22: 885-895.
12. Johnson VE, Stewart JE, Begbie FD, et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013; 135: 28-42.
13. Smith DH, Chen XH, Pierce JE, et al. Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 1997; 14: 715-727.
14. Zhu G, Okada M, Yoshida S, et al. Effects of interleukin-1beta on hippocampal glutamate and GABA releases associated with Ca2+-induced Ca2+ releasing systems. Epilepsy Res 2006; 71: 107-116.
15. Vezzani A, Moneta D, Conti M, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000; 97: 11534-11539.
16. Ravizza T, Lucas SM, Balosso S, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006; 47: 1160-1168.
17. Rijkers H, Majoie HJ, Hoogland G, et al. The role of interleukin-1 in seizures and epilepsy: a critical review. Exp Neurol 2009; 216: 258-271.
18. Darrah SD, Miller MA, Ren D, et al. Genetic variability in glutamic acid decarboxylase genes: associations with post-traumatic seizures after severe TBI. Epilepsy Res 2013; 103: 180-194.
19. Wagner AK, Miller MA, Scanlon J, et al. Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. Epilepsy Res 2010; 90: 259-272.
20. Kauffman MA, Moron DG, Consalvo D, et al. Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med 2008; 10: 83-88.
21. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004; 50: 1976-1983.
22. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470-472.
23. Bratton SL, Bullock RM, Carney N, et al. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007; 24: s37-s44.
24. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990; 323: 497-502.
25. Gennarelli TA, Wodzin E,. AIS 2005: a contemporary injury scale. Injury 2006; 37: 1083-1091.
26. Baker SP, O'Neill B, Haddon W Jr, et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14: 187-196.
27. Berry C, Ley EJ, Tillou A, et al. The effect of gender on patients with moderate to severe head injuries. J Trauma 2009; 67: 950-953.
28. Miller SA, Dykes DD, Polesky HF,. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
29. Mellergard P, Aneman O, Sjogren F, et al. Differences in cerebral extracellular response of interleukin-1β, interleukin-6, and interleukin- 10 after subarachnoid hemorrhage or severe trauma in humans. Neurosurgery 2011; 68: 12-19.
30. Camargo MC, Mera R, Correa P, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1674-1687.
31. National Institute of Neurological Disorders and Stroke. Epilepsy research benchmarks progress report 2007-2012 [document on the internet]. NINDS online; 2013. Available at: http://www.ninds.nih.gov/research/epilepsyweb/ benchmarks-2007-2012progress.pdf. Accessed September 4, 2013.
32. Zou H, Brayer SW, Hurwitz M, et al. Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehabil Neural Repair 2013; 27: 878-888.
33. Omran A, Peng J, Zhang C, et al. Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012; 53: 1215-1224.
34. Allan SM, Tyrrell PJ, Rothwell NJ,. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005; 5: 629-640.
35. Acosta SA, Tajiri N, Shinozuka K, et al. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS ONE 2013; 8: e53376.
36. Boles J, Goyal A, Kumar R, et al. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome. 2013. Presented at Annual Symposium of the National Neurotrauma Society; Phoenix, Arizona; 2012 July 22-25.
37. Das M, Mohapatra S, Mohapatra SS,. New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation 2012; 9: 236.
38. Skinner RA, Gibson RM, Rothwell NJ, et al. Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 2009; 156: 1115-1123.
39. Aibiki M, Maekawa S, Ogura S, et al. Effect of moderate hypothermia on systemic and internal jugular plasma IL-6 levels after traumatic brain injury in humans. J Neurotrauma 1999; 16: 225-232.
40. Helmy A, Carpenter KLH, Menon DK, et al. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab 2011; 31: 658-670.
41. Lee SC, Liu W, Dickson DW, et al. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 1993; 150: 2659-2667.
42. Brown R, Li Z, Vriend CY, et al. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1 beta: evidence for pituitary-adrenal and sympathetic control. Cell Immunol 1991; 132: 84-93.
43. Van der Zee CE, Rashid K, Le K, et al. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 1995; 15: 5316-5323.
44. Spranger M, Lindholm D, Bandtlow C, et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1990; 2: 69-76.
45. DeKosky ST, Goss JR, Miller PD, et al. Upregulation of nerve growth factor following cortical trauma. Exp Neurol 1994; 130: 173-177.
46. DeKosky ST, Styren SD, O'Malley ME, et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol 1996; 39: 123-127.
47. Von Wedel-Parlow M, Wolte P, Galla HJ, et al. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J Neurochem 2009; 111: 111-118.
48. Pociot F, Mølvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
49. Santarsieri M, Niyonkuru C, McCullough EH, et al. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J Neurotrauma 2014; 31: 699-712.
50. Schmitz G, Kaminski WE, Porsch-Ozcurumez M, et al. ATP-binding cassette transporter A1 (ABCA1) in macrophages: a dual function in inflammation and lipid metabolism. Pathobiology 1999; 67: 236-240.
51. Hamon Y, Luciani MF, Becq F, et al. Interleukin-1beta secretion is impaired by inhibitors of the ATP bind cassette transport, ABC1. Blood 1997; 90: 2911-2915.
52. Gao WM, Chadha MS, Kline AE, et al. Immunohistochemical analysis of histone H3 acetylation and methylation-evidence for altered epigenetic signaling following traumatic brain injury in immature rats. Brain Res 2006; 1070: 31-34.
53. Chen H, Wilkins LM, Aziz N, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 2006; 15: 519-529.
54. Chen X, El Gazzar M, Yoza BK, et al. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 2009; 284: 27857-27865.
55. Dominici R, Malferrari G, Mariani C, et al. The Interleukin 1-beta exonic (+3953) polymorphism does not alter in vitro protein secretion. Exp Mol Pathol 2002; 73: 139-141.